Hosted on MSN
Researchers study adults with hypoplastic left heart syndrome (HLHS) thriving without transplants
Researchers at Children's Hospital of Philadelphia (CHOP) reported long-term clinical outcomes for the largest single center cohort of individuals who underwent complex reconstructive surgery for ...
Longeveron Inc. has completed enrollment for its Phase 2b clinical trial, ELPIS II, which is testing laromestrocel, a cellular therapy aimed at improving outcomes in infants with Hypoplastic Left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results